These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1088 related items for PubMed ID: 23216616

  • 1. Cardiovascular events and intensity of treatment in polycythemia vera.
    Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T, CYTO-PV Collaborative Group.
    N Engl J Med; 2013 Jan 03; 368(1):22-33. PubMed ID: 23216616
    [Abstract] [Full Text] [Related]

  • 2. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A, Pérez-Encinas M, Ferrer-Marín F, Hernández-Boluda JC, Ramírez MJ, Martínez-López J, Magro E, Cruz Y, Mata MI, Aragües P, Fox ML, Cuevas B, Montesdeoca S, Hernández-Rivas JA, García-Gutiérrez V, Gómez-Casares MT, Steegmann JL, Durán MA, Gómez M, Kerguelen A, Bárez A, García MC, Boqué C, Raya JM, Martínez C, Albors M, García F, Burgaleta C, Besses C, Grupo Español de Neoplasias Mieloproliferativas Filadelfia Negativas.
    Haematologica; 2017 Jan 03; 102(1):103-109. PubMed ID: 27686377
    [Abstract] [Full Text] [Related]

  • 3. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar 03; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

  • 4. Treatment target in polycythemia vera.
    Marchioli R, Vannucchi AM, Barbui T.
    N Engl J Med; 2013 Apr 18; 368(16):1556. PubMed ID: 23594012
    [No Abstract] [Full Text] [Related]

  • 5. Treatment target in polycythemia vera.
    McMullin MF, Harrison CN, Kiladjian JJ.
    N Engl J Med; 2013 Apr 18; 368(16):1554-5. PubMed ID: 23594013
    [No Abstract] [Full Text] [Related]

  • 6. Treatment target in polycythemia vera.
    Leone G.
    N Engl J Med; 2013 Apr 18; 368(16):1555. PubMed ID: 23594014
    [No Abstract] [Full Text] [Related]

  • 7. Treatment target in polycythemia vera.
    Prchal JT, Gordeuk VR.
    N Engl J Med; 2013 Apr 18; 368(16):1555-6. PubMed ID: 23594015
    [No Abstract] [Full Text] [Related]

  • 8. Treatment target in polycythemia vera.
    Spivak JL.
    N Engl J Med; 2013 Apr 18; 368(16):1556-7. PubMed ID: 23599949
    [No Abstract] [Full Text] [Related]

  • 9. Polycythemia vera, the hematocrit, and blood-volume physiology.
    Spivak JL.
    N Engl J Med; 2013 Jan 03; 368(1):76-8. PubMed ID: 23216617
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr 03; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of low-dose aspirin in polycythemia vera.
    Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, Barbui T, European Collaboration on Low-Dose Aspirin in Polycythemia Vera Investigators.
    N Engl J Med; 2004 Jan 08; 350(2):114-24. PubMed ID: 14711910
    [Abstract] [Full Text] [Related]

  • 12. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T.
    J Clin Oncol; 2005 Apr 01; 23(10):2224-32. PubMed ID: 15710945
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic options for essential thrombocythemia and polycythemia vera.
    Solberg LA.
    Semin Oncol; 2002 Jun 01; 29(3 Suppl 10):10-5. PubMed ID: 12096352
    [Abstract] [Full Text] [Related]

  • 14. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S, Michiels JJ.
    Semin Thromb Hemost; 2006 Jun 01; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [Abstract] [Full Text] [Related]

  • 15. [True polycythemia: current views of pathogenesis, diagnostics and treatment].
    Vatutin NT, Taradin GG, Bakhteeva TD, Kalinkina NV, Skliannaia EV.
    Klin Med (Mosk); 2012 Jun 01; 90(8):24-31. PubMed ID: 23101255
    [Abstract] [Full Text] [Related]

  • 16. How to manage polycythemia vera.
    Passamonti F.
    Leukemia; 2012 May 01; 26(5):870-4. PubMed ID: 22157736
    [Abstract] [Full Text] [Related]

  • 17. The haematocrit and platelet target in polycythemia vera.
    Di Nisio M, Barbui T, Di Gennaro L, Borrelli G, Finazzi G, Landolfi R, Leone G, Marfisi R, Porreca E, Ruggeri M, Rutjes AW, Tognoni G, Vannucchi AM, Marchioli R, European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) Investigators.
    Br J Haematol; 2007 Jan 01; 136(2):249-59. PubMed ID: 17156406
    [Abstract] [Full Text] [Related]

  • 18. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
    Tiziana Storlazzi C, Pieri L, Paoli C, Daniele G, Lasho T, Tefferi A, Vannucchi AM.
    Am J Hematol; 2014 Apr 01; 89(4):438-42. PubMed ID: 24382738
    [Abstract] [Full Text] [Related]

  • 19. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S, Stock W, Godwin J, Fisher SG.
    Am J Hematol; 1996 May 01; 52(1):42-6. PubMed ID: 8638610
    [Abstract] [Full Text] [Related]

  • 20. Treatment of polycythemia vera.
    Silver RT.
    Semin Thromb Hemost; 2006 Jun 01; 32(4 Pt 2):437-42. PubMed ID: 16810620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.